Ranbaxy has declared its fourth quarter results. Its Q4 standalone net sales at Rs 993.32 crore versus Rs 1,005.85 crore, YoY.
Its standalone net profit up at Rs 301.60 crore versus Rs 201.03 crore, YoY.
Its standalone net profit up at Rs 301.60 crore versus Rs 201.03 crore, YoY.
| Result (Rs cr) | Dec-07 | Sep-07 | Jun-07 | Mar-06 | Dec-06 |
| Net Sales / Interest Earned / Operating Income | 993 | 1038 | 1015 | 988 | 1006 |
| Other Income | 125 | 115 | 73 | 28 | 29 |
| Total Income | 1118 | 1153 | 1088 | 1016 | 1035 |
| Expenditure | -1007 | -883 | -674 | -827 | -831 |
| Operating Profit | 111 | 270 | 414 | 189 | 204 |
| Interest | -25 | -26 | -25 | -16 | -14 |
| Profit Before Depreciation and Tax | 87 | 244 | 389 | 173 | 191 |
| Depreciation | -30 | -33 | -28 | -29 | -25 |
| Profit before Tax | 57 | 211 | 361 | 144 | 165 |
| Tax | -8 | -43 | -70 | -38 | -26 |
| Profit after Tax | 48 | 168 | 291 | 106 | 139 |
| Extraordinary Items | - | - | - | 9 | - |
| Net Profit | 48.40 | 168.16 | 291.15 | 115.28 | 139.07 |
| Equity Capital | 186.54 | 186.48 | 186.43 | 186.39 | 186.34 |
